Ilko And Genexine Collaborate To Manufacture Biotechnological Medicines

News: Turkey-based pharmaceutical company Ilko Ilac will collaborate with South Korea-based biotech company Genexine to manufacture biotechnological medicines in Konya, Turkey, reports The two companies will establish an equal partnership to manufacture biotechnological medicines to be used in the treatment of cancer patients. The move will be the first investment related to the research and development of biotechnological medicines in the country. The Ilko-Genexine collaboration is likely to invest US$32.4mn in its first phase to develop and manufacture cancer and cancer-related biotechnological medicines.

This article is tagged to:
Related sectors of this article: Pharmaceuticals & Healthcare, Biotechnology, Agreements - Pharmaceuticals
Geography: Turkey

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.